MedTrace Logo

Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)

NCT05763407 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2026-04-17

No results posted yet for this study

Summary

Early Feasibility Study of the NORM™ System in Heart Failure Patients

Conditions

Interventions

DEVICE

NORM™ System

NORM™ System

Sponsors & Collaborators

  • Foundry Innovation & Research 1, Limited (FIRE1)

    lead INDUSTRY

Principal Investigators

  • Carolyn Borme · Director Clinical US

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-19
Primary Completion
2026-06-30
Completion
2027-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05763407 on ClinicalTrials.gov